China Health Appeals Chengde Court Ruling in Contract Dispute

MT Newswires Live
07/14

China Health (HKG:0673) filed a civil appeal against a first-instance court ruling in its contract dispute with the People's Government of Shuangluan District, Chengde City, and a local hospital, according to a Monday filing with the Hong Kong bourse.

The dispute stems from a 2015 hospital cooperation agreement that was terminated in 2021. China Health sued to recover more than 59.1 million yuan in outstanding loans and interest.

In May, the Chengde Intermediate People's Court ordered the hospital to repay 46.5 million yuan in outstanding principal plus interest, but dismissed the company's remaining claims, including those against the district government.

China Health seeks to overturn the judgment, uphold all of its original claims, and require the defendants to bear the litigation costs in both instances.

The company said the appeal argues that the court erred in determining key facts, omitted crucial evidence and misapplied the law.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10